GlaxoSmithKline (GSK) and Theravance have received marketing authorization from the European Commission (EC) for their jointly-developed asthma and chronic obstructive pulmonary disease (COPD) drug 'Relvar Ellipta'. Relvar, which is a ...
Tags: GSK, Relvar Ellipta
Teva Pharmaceutical Industries has signed an agreement to purchase pharmaceutical and drug delivery company, MicroDose Therapeutx, to strengthen its respiratory franchise. The deal involves acquisition of all of MicroDose's outstanding ...
GlaxoSmithKline (GSK) and Theravance have announced the FDA approval of Breo Ellipta as maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD) patients. The inhaled long-term, once-daily maintenance ...
Tags: GSK, Theravance, Copd Therapy
Forest Laboratories and Almirall have reported positive results from the ACLIdinium/FORMoterol fumarate combination for Investigative use in the treatment of moderate to severe COPD (ACLIFORM/COPD) Phase III study. ACLIFORM/COPD is the ...
Mylan, a generic pharmaceutical manufacturer, will spend $100m in Ireland over the next five years to expand its operations in the cities of Dublin and Galway. Through the investment, Mylan is expected to add more than 500 new positions ...
Sunovion Pharmaceuticals is set to launch Zetonna (ciclesonide) nasal aerosol, a non-aqueous, dry nasal aerosol spray for allergic rhinitis in the third quarter of 2012 in the US. The 74mcg once-daily product is indicated for the ...
Tags: Sunovion Pharmaceuticals, Medicine, Zetonna nasal aerosol